The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...